« Back to Record
Gatell, J., Guaraldi, G. P., Masia, M., Gompels, M., De Wit, S., Florence, E., Esser, S., Raffi, F., Pozniak, A. L., Assoumou, L., Moyle, G., Waters, L., Johnson, M., Domingo, P., Fox, J., Martinez, E., & Stellbrink, H.-J. (2017). Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular risk. AIDS, 31(18), 2503-2514. doi:10.1097/QAD.0000000000001675
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/261870



